Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

CV 3988 MeSH Supplementary Concept Data 2025


MeSH Supplementary
CV 3988
Unique ID
C037913
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C037913
Entry Term(s)
2-methoxy-3-(octadecylcarbamoyloxy)propyl-2-(3-thiazolinium) ethyl phosphate
3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphate
3-MOTP
CV-3988
CV3988
Pharm Action
Platelet Aggregation Inhibitors
Registry Numbers
85703-73-7
CAS Type 1 Name
Thiazolium, 3-(4-hydroxy-7-methoxy-10-oxo-3,5,9-trioxa-11-aza-4-phosphanonacos-1-yl)-, hydroxide, inner salt, P-oxide, (+-)-
Previous Indexing
*THIAZOLES (1975-1988)
Heading Mapped to
*Phospholipid Ethers
Frequency
195
Note
platelet activating factor antagonist; structure given in first source
Source
Life Sci 1983;32(17):1975
Date of Entry
1983/05/13
Revision Date
2006/09/27
CV 3988 Preferred
2-methoxy-3-(octadecylcarbamoyloxy)propyl-2-(3-thiazolinium) ethyl phosphate Broader
page delivered in 0.009s